Term
Hyperthyroidism/Thyrotoxicosis |
|
Definition
elevated levels of T3 and T4
caused by Graves' disease, hyperfunctional multilobular goiter, or hyperfunctional adenoma
increases BMR
skin is soft, warm, flushed; heat intolerance; weight loss; increased sweating; increased cardiac output, tachycardia, palpitations, cardiomegaly, arrythmias; wide, staring gaze; GI hypermotility, malabsorption, diarrhea; osteoporosis |
|
|
Term
Thyrotoxic/Hyperthyroid cardiomyopathy |
|
Definition
left ventricular dysfunction and low-output heart failure caused by thyrotoxicosis |
|
|
Term
|
Definition
abrupt onset of severe hyperthyroidism
most common in underlying Graves' disease
probably a result of an acute elevation in catcholamine levels (infection, surgery, stress)
pts are febrile and present with tachycardia out of proportion to the fever
medical emergency! |
|
|
Term
Apathetic hyperthyroidism |
|
Definition
thyrotoxicosis in the elderly, when advancing age and co-morbidities may blunt the typical presenting features of thyroid excess |
|
|
Term
|
Definition
hypothyroidism and sensorineural deafness
caused by mutations in the SLC26A4 gene
pendrin product is an anion transporter on the apical surface of thyrocytes and inner ear |
|
|
Term
|
Definition
hypothyroidism that develops in infancy or early childhood
impaired development of skeletal system and CNS
severe mental retardation, short stature, coarse facial features, protruding tongue, umbilical hernia
severity correlates to time of thyroid deficiency in utero |
|
|
Term
|
Definition
hypothyroidism developing in the older child or adult
Overall physical and mental slowing: fatigue, apathy, mental sluggishness, cold intolerant, overweight, cool, pale skin, reduced cardiac output (causes shortness of breath, less exercise capacity)
increase in total cholesterol and LDL
accumulation of glycosaminoglycans and hyaluronic acid in skin and subcutaneous tissue --> non-pitting edema, a broadening and coarsening of facial features, tongue enlargement, deepening of voice
T4 is decreased; TSH is increased |
|
|
Term
|
Definition
autoimmune hypothyroidism caused by autoantibodies against thyroglobulin and thyroid peroxidase
CTLA4, PTPN22 genes associated
CD8+ cytotoxic T cell and cytokine (TH1, interferon γ)-mediated cell death
diffusely enlarged thyroid; pale, yellow-tan, firm, nodular
extensive mononuclear inflammatory infiltrate and germinal centers
atrophic follicles lined by Hurthle cells (epithelial cells with abundant, eosinophilic, granular cytoplasm)
fibrous variant = severe thyroid follicular atrophy and dense "keloid-like" fibrosis, broad bands of acellular collagen encompassing residual thyroid tissue
increased risk of B-cell non-Hodgkin lymphoma |
|
|
Term
|
Definition
transient hyperthyroidism caused by disruption of thyroid follicles, with secondary release of thyroid hormones
eventually, hypothyroidism ensues |
|
|
Term
Subacute (granulomatous) thyroiditis
De Quervain thyroiditis |
|
Definition
believed to be virally triggered, particular after URI
most common cause of thyroid pain
unilaterally or bilaterally enlarged thyroid; firm, with intact capsule; involved areas are firm, yellow-white; patchy
aggregates of lymphocytes, activated macrophages, and plasma cells about collapsed, damaged follicles
multinucleate giant cells enclose fragments of colloid (granulomatous thyroiditis)
painful w/ visible enlargement; iodine uptake decreased; high T4 and T3, low TSH
transient hyperthyroidism recovers in 6-8 wks |
|
|
Term
Subacute Lymphocytic (Painless) Thyroiditis |
|
Definition
mild hyperthyroidism, painless goitrous thyroid enlargement
usually middle-aged women
variant of Hashimoto; circulating anti-thyroid peroxidase antibodies; often a family history of autoimmunity
thyroid appears grossly normal
lymphocytic infiltration with hyperplastic germinal centers within the thyroid parenchyma
patchy disruption and collapse of thyroid follicles
no fibrosis or Hurthle cells |
|
|
Term
|
Definition
variant of Hashimoto occuring postpartum
circulating antibodies to thyroid peroxidase or family history of autoimmunity
transient hyperthyroidism
usually euthyroid within a year |
|
|
Term
|
Definition
extensive fibrosis involving the thyroid and contiguous neck structures |
|
|
Term
|
Definition
hyperthyroidism, opthalmopathy with resultant exopthalmos, dermopathy (pretibial myxedema)
polymorphisms in CTLA4, PTPN22, HLA-DR3
presence of thyroid-stimulating antibodies (IgG), thyroid growth-stimulating Igs, TSH binding inhibitor Igs
diffuse, symmetrical hypertrophy and hyperplasia
parenchyma is soft, meaty; crowded follicular epithelial cells may form small papillae
colloid is pale w/ scalloped margins; T cell predominant lymphoid infiltrate; germinal centers
sympathetic overactivity
inc. T4 and T3; dec. TSH; diffuse iodine uptake |
|
|
Term
|
Definition
caused by infiltration of mononuclear cells (T cells) inflammatory edema and swelling of extraocular muscles
accumulation of ECM glycosaminoglycans (hyaluronic acid, chondroitan sulfate)
increased adipocytes |
|
|
Term
Diffuse Nontoxic (Simple) Goiter |
|
Definition
thyroid enlargement w/o nodularity; impaired synthesis of thyroid hormone
iodine deficiency, goitrogens, sporadic
hyperplastic phase - diffuse, symmetrical gland enlargement; follicles lined with crowded columnar cells
colloid involution - if iodine is increased or TH demand increases, follicular epithleium involutes to form an enlarged, colloid-rich gland; brown, glassy, somewhat translucent; follicular epithelium is flattened, cuboidal; abundant colloid
symptoms related to mass effect
T3 and T4 normal; TSH elevated/upper range of normal |
|
|
Term
|
Definition
caused by recurrent episodes of hyperplasia and involution
polyclonal and monoclonal nodules coexist
multilobulated with unpredictable enlargement pattern
intrathoracic/plunging goiter = behind sternum, clavicles
irregular nodules w variable amts of brown gelatinous colloid
older lesions have areas of hemorrhage, fibrosis, calcification, cystic change
colloid-rich follicles lined by flattened, inactive epithelium and areas of follicular hyperplasia
symptoms due to mass effects
uneven iodine uptake |
|
|
Term
|
Definition
a multinodular goiter in which an autonomous nodule may develop and produce hyperthyroidism (toxic multinodular goiter)
not accompanied by infiltrative opthalmopathy or dermopathy |
|
|
Term
Thyroid adenomas
(follicular adenomas) |
|
Definition
solitary, well-demarcated, spherical, encapsulated lesion
RAS, PIK3CA, PAX8-PPARG fusion gene; GOF mutations in TSHR or GNAS for toxic lesions
gray-white to red-brown; well-defined, intact capsule
may have areas of hemorrhage, fibrosis, calcification, cystic change
uniform-appearing cells that contain colloid
unilateral, painless mass; difficulty swallowing
Hurthle cell adenoma is a variant
nonfunctioning = cold nodules on radioscan
toxic = hot nodules |
|
|
Term
|
Definition
most common thyroid carcinoma (>85%)
activation of MAP kinase pathway due to rearrangement of RET/PTC or NTRK1 or GOF point mutation in BRAF
most common b/w 25 and 50; previous ionizing radiation
branching papillae with a fibrovascular stalk covered by cuboidal epithelial cells
ground-glass/Orphan Annie eye nuclei w/ intranuclear inclusions (pseudo-inclusions)
psammoma bodies (concentric calcifications)
foci of lympathic invasion |
|
|
Term
Follicular variant of papillary carcinoma |
|
Definition
has the characteristic nuclei of papillary carcinoma but has an almost totally follicular architecture
lower frequency of RET/PTC rearrangements; higher frequency of RAS mutations; distinct mutation in BRAF, resulting in a lower degrees of BRAF kinase activation
more frequenctly encapsulated; lower incidence of lymph node metastases and extra-thyroidal extension |
|
|
Term
Tall cell variant of papillary carcinoma |
|
Definition
papillary carcinoma marked by tall columnar cells with intensely eosinophilic cytoplasm lining the papillary structures
older age occurrence; high frequencies of vascular invasion, extra-thyroidal extension, cervical and distant metastases; more aggressive
BRAF mutations in most cases (55-100%), often with RET/PTC translocation |
|
|
Term
Diffuse sclerosing variant of papillary carcinoma |
|
Definition
papillary carcinoma occuring in younger individuals, including children
prominent papillary growth pattern, intermixed with solid areas containing nests of squamous metaplasia
extensive, diffuse fibrosis; often with prominent lymphocytic infiltrate
lymph node metastases are always present
no BRAF mutations; RET/PTC mutation in half of cases |
|
|
Term
|
Definition
thyroid cancer more frequent in areas of iodine deficiency
well-circumscribed or infiltrative single nodules
gray to tan to pink; may be translucent
uniform cells forming small follicles containing colloid
NO psammoma bodies; NO orphan annie nuclei
may be minimally or widely invasive
slowly enlarging, painless nodule; cold on scintigrams
tx with total thyroidectomy |
|
|
Term
Hurthle cell or oncocytic variant of follicular carcinoma |
|
Definition
follicular carcinoma dominated by cells with abundant granular eosinophilc cytoplasm (Hurthle cells) |
|
|
Term
widely invasive follicular carcinoma |
|
Definition
follicular carcinoma that tends to have a greater proportion of solid or trabecular growth pattern, less evidence of follicular differentiation, and increased mitotic activity
infiltrates thyroid parenchyma and adjacent soft tissues
50% mortality rate within 10 yrs
|
|
|
Term
Anaplastic (undifferentiated) Carcinoma |
|
Definition
undifferentiated tumors of the thyroid follicular epithelium
aggressive, close to 100% mortality rate
mean age of 65
highly anaplastic cells with large, pleomorphic giant cells, spindle cells and mixed spindle and giant cells
neoplastic cells express markers for cytokeratin
rapidly enlarging bulky neck mass
dyspnea, dysphagia, hoarseness, cough |
|
|
Term
|
Definition
neuroendocrine neoplasms derived from parafollicular C cells; secrete calcitonin
70% sporadic; rest as part of MEN 2A or 2B or FMTC
assoc. w/ point mutations in RET proto-oncogene
sporadic origin = solitary; familial = bilateral, multicentric
polygonal to spindle-shaped cells that may form nests, trabeculae, or follicles; acellular amyloid deposits in the adjacent stroma from altered calcitonin polypeptides
familial only = C cell hyperplasia
NO hypocalcemia |
|
|
Term
|
Definition
solitary, well-circumscribed, soft, tan to reddish brown
glands outside the nodule are normal in size or shrunken due to inhibition by elevated serum calcium
composed of uniform, polygonal chief cells with small, centrally placed nuclei; sometimes, bizarre or pleomorphic (endocrine atypia)
always few nests of larger oxyphil cells
rim of compressed non-neoplastic tissue separated by a fibrous capsule
hypercalcemia; serum PTH is inappropriately elevated for the levels of serum Ca2+
hypophophatemia, increased urinary excretion of phosphate and calcium |
|
|
Term
|
Definition
cause of hyperparathyroidism; increased [PTH]
frequent asymmetry; classically, all four glands involved
chief cell hyperplasia in a diffuse to multinodular pattern
constituent cells may contain abundant water clear cells; called "water-clear cell hyperplasia"
islands of oxyphils are present; poorly developed, delicate fibrous strands envelop nodule; no stromal fat |
|
|
Term
|
Definition
enlargement of one parathyroid gland
gray-white, irregular mass
cell are usually uniform, resemble normal parathyroid cells
nodular or trabecular patterns with a dense fibrous capsule
must have invasion of surrounding tissues and metastasis
malignancy is the most common cause of symptomatic hypercalcemia: "painful bones, renal stones, abdominal groans, psychic moans" |
|
|
Term
Primary hyperparathyroidism |
|
Definition
most common cause of asymptomatic hypercalcemia
serum PTH levels are inappropriately elevated for the level of serum calcium
caused by adenoma, primary hyperplasia |
|
|
Term
Secondary hyperparathyroidism |
|
Definition
any condition that causes chronic hypocalcemia
usually renal failure
parathyroid glands are hyperplastic, not necessarily symmetric
increased number of chief cells; more water clear cells
decreased fat cells; bone changes and metastatic calcification are common
condition is dominated by symptoms of chronic renal failure: renal osteodystrophy, calciphylaxis (vascular calcifications that damage other organs and skin)
usually respond to dietary vitamin D supplements and phosphate binders |
|
|
Term
Autoimmune polyendocrine syndrome type 1 |
|
Definition
autoimmune hypoparathyroidism caused by mutation in AIRE gene
chronic mucocutaneous candidiasis and primary adrenal insufficiency
typically presents in childhood with the onset of candidiasis |
|
|
Term
Autosomal dominant hypoparathyroidism |
|
Definition
caused by gain of function mutations in the calcium-sensing receptor (CASR)
suppresses PTH, leading to hypocalcemia and hypercalciuria |
|
|
Term
Familial isolated hypoparathyroidism (FIH) |
|
Definition
autosomal dominant or recessive hypoparathyroidism
autosomal dominant = mutation in the gene encoding PTH precursor peptide
autosomal recessive caused by loss of function mutations in the transcription factor gene glial cells missing-2 (GCM2), essential for parathyroid development |
|
|
Term
|
Definition
usually related to hypocalcemia
tetany, Chvostek sign and Trousseau sign, mental status change (instability, anxiety, depression, psychosis, etc.), intracranial manifestations like calcifications of the basal ganglia, parkinsonian-type movement disorders and increased ICP, ocular disease with calcification of the lens and cataract formation, prolonged QT interval, dental abnormalities |
|
|
Term
Morphologic changes associated with hyperparathyroidism |
|
Definition
Skeletal changes: increased osteoclasts, increased osteoblastic activity; resultant bone contains widely spaced, delicate trabeculae like those seen in osteoporosis; may lead to osteitis fibrosa cystica, w/ increased amts of fibrous tissue, hemmorhagic foci and cyst formation
Brown tumors: aggregates of osteoclasts, reactive giant cells, and hemorrhagic debris that may be mistaken for neoplasms
Nepholithiasis: due to PTH-induced hypercalcemia
Extra-parathyroid metastatic calcifications
|
|
|
Term
|
Definition
hypoparathyroidism due due end-organ resistance to the actions of PTH
serum PTH is normal or elevated
can be multi-hormone end-organ resistance, including TSH and FSH/LH
genetic defects in G-protein-second-messenger pathways
presents as hypocalcemia, hyperphosphatemia, elevated PTH
LH/FSH resistance presents as hypergonodatropic hypogonadism in females |
|
|